| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |